Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD.
作者信息
Huang George X, Palumbo Marina L, Singer Joseph I, Cahill Katherine N, Laidlaw Tanya M
机构信息
Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Mass.
出版信息
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1647-1649. doi: 10.1016/j.jaip.2019.02.037. Epub 2019 Mar 12.
Abstract
摘要
相似文献
1
Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD.鼻窦手术可改善阿司匹林三联征患者在阿司匹林脱敏治疗期间的下呼吸道反应性。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1647-1649. doi: 10.1016/j.jaip.2019.02.037. Epub 2019 Mar 12.
2
Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.阿司匹林诱发的呼吸道疾病中阿司匹林脱敏治疗的长期鼻窦结局
Otolaryngol Head Neck Surg. 2014 Oct;151(4):575-81. doi: 10.1177/0194599814545750. Epub 2014 Aug 12.
3
Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.阿司匹林加重的呼吸道疾病行完全内镜鼻窦手术后和阿司匹林脱敏治疗的结果。
Int Forum Allergy Rhinol. 2018 Jan;8(1):49-53. doi: 10.1002/alr.22036. Epub 2017 Nov 3.
4
Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.阿司匹林脱敏治疗中鼻窦和肺部的客观与主观结果：一项前瞻性队列研究。
Auris Nasus Larynx. 2019 Aug;46(4):526-532. doi: 10.1016/j.anl.2018.12.002. Epub 2018 Dec 19.
5
AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.变应性支气管肺曲霉菌病相关鼻息肉：与阿司匹林脱敏相比，术后抗白三烯治疗的疗效。一项回顾性研究。
Int Arch Allergy Immunol. 2020;181(10):790-798. doi: 10.1159/000508708. Epub 2020 Aug 10.
6
Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.在一名患有阿司匹林加重性呼吸系统疾病的患者中成功进行了长期的阿司匹林脱敏治疗。
Mil Med. 2023 Jul 22;188(7-8):e2826-e2828. doi: 10.1093/milmed/usac344.
7
Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.内镜鼻窦手术可改善阿司匹林加重呼吸道疾病患者对阿司匹林的治疗反应。
Int Forum Allergy Rhinol. 2019 Dec;9(12):1401-1408. doi: 10.1002/alr.22418. Epub 2019 Sep 30.
8
Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.阿司匹林诱发的呼吸道疾病患者每日持续服用阿司匹林进行脱敏治疗的长期临床疗效
Am J Rhinol Allergy. 2018 Jul;32(4):280-286. doi: 10.1177/1945892418770260. Epub 2018 Apr 23.
9
Central compartment involvement in aspirin-exacerbated respiratory disease: the role of allergy and previous sinus surgery.中央隔室受累与阿司匹林加重的呼吸道疾病：过敏和既往鼻窦手术的作用。
Int Forum Allergy Rhinol. 2019 Sep;9(9):1017-1022. doi: 10.1002/alr.22367. Epub 2019 Jun 27.
10
Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.哮喘患者中阿司匹林加重性呼吸系统疾病的流行情况：文献荟萃分析。
J Allergy Clin Immunol. 2015 Mar;135(3):676-81.e1. doi: 10.1016/j.jaci.2014.08.020. Epub 2014 Oct 3.
引用本文的文献
1
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.更新非甾体抗炎药超敏反应的分类与常规诊断：世界变态反应组织声明
World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086. eCollection 2025 Aug.
2
Consultation for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Clinical Presentation, Diagnostic Workup, and Treatment Options.慢性鼻-鼻窦炎伴鼻息肉和哮喘患者的就诊：临床表现、诊断方法和治疗选择。
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2898-2905. doi: 10.1016/j.jaip.2024.07.019. Epub 2024 Jul 30.
3
[Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs （2024, Chengdu）].非甾体抗炎药诱发的呼吸系统疾病诊治专家共识（2024年，成都）
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Jun;38(6):453-462. doi: 10.13201/j.issn.2096-7993.2024.06.001.
4
Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?在阿司匹林加重的呼吸道疾病中，是否应该在阿司匹林脱敏之前使用生物制剂？
J Allergy Clin Immunol Pract. 2024 Jan;12(1):79-84. doi: 10.1016/j.jaip.2023.09.019. Epub 2023 Sep 29.
5
The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).氧化应激产物在非甾体抗炎药加重的呼吸道疾病（N-ERD）中的作用。
Adv Pharmacol. 2023;97:423-444. doi: 10.1016/bs.apha.2022.12.002. Epub 2023 Jan 10.
6
Aspirin-exacerbated respiratory disease: Updates in the era of biologics.阿司匹林加重性呼吸系统疾病：生物制剂时代的新进展。
Ann Allergy Asthma Immunol. 2023 Sep;131(3):317-324. doi: 10.1016/j.anai.2023.05.016. Epub 2023 May 22.
7
Mechanistic and clinical updates in AERD: 2021-2022.变应性支气管肺曲霉菌病的机制和临床新进展：2021-2022 年。
J Allergy Clin Immunol. 2023 Jun;151(6):1448-1456. doi: 10.1016/j.jaci.2023.03.015. Epub 2023 Mar 24.
8
Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index.阿司匹林诱发的呼吸反应的介质产生与严重程度：采样部位和体重指数的影响
J Allergy Clin Immunol. 2022 Jul;150(1):170-177.e6. doi: 10.1016/j.jaci.2021.12.787. Epub 2022 Jan 11.
9
Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease.评估生物疗法在阿司匹林加重性呼吸道疾病中的真实世界疗效。
J Allergy Clin Immunol Pract. 2022 Feb;10(2):478-484.e3. doi: 10.1016/j.jaip.2021.09.030. Epub 2021 Sep 28.
10
Biomarkers for predicting response to long-term high dose aspirin therapy in aspirin-exacerbated respiratory disease.用于预测阿司匹林诱发的呼吸道疾病患者对长期高剂量阿司匹林治疗反应的生物标志物。
Clin Transl Allergy. 2021 Aug 13;11(6):e12048. doi: 10.1002/clt2.12048. eCollection 2021 Aug.
本文引用的文献
1
Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.鼻窦手术可降低阿司匹林加重的呼吸道疾病患者阿司匹林诱导反应的严重程度。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1580-1588. doi: 10.1016/j.jaip.2018.12.014. Epub 2018 Dec 21.
2
A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.阿司匹林加重的呼吸道疾病 1 日 90 分钟阿司匹林挑战及脱敏方案。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1174-1180. doi: 10.1016/j.jaip.2018.10.032. Epub 2018 Nov 2.
3
Aspirin-Exacerbated Respiratory Disease.阿司匹林加重性呼吸道疾病
N Engl J Med. 2018 Sep 13;379(11):1060-1070. doi: 10.1056/NEJMra1712125.
4
Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.阿司匹林加重的呼吸道疾病行完全内镜鼻窦手术后和阿司匹林脱敏治疗的结果。
Int Forum Allergy Rhinol. 2018 Jan;8(1):49-53. doi: 10.1002/alr.22036. Epub 2017 Nov 3.
5
The minimally important difference of the Asthma Control Test.哮喘控制测试的最小重要差异。
J Allergy Clin Immunol. 2009 Oct;124(4):719-23.e1. doi: 10.1016/j.jaci.2009.06.053. Epub 2009 Sep 19.
6
Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily.阿司匹林脱敏的长期治疗：一项比较每日服用100毫克和300毫克阿司匹林的前瞻性临床试验。
Allergy. 2008 Sep;63(9):1228-34. doi: 10.1111/j.1398-9995.2008.01658.x.
7
Medical and surgical considerations in patients with Samter's triad.阿司匹林三联征患者的医学与外科考量
Am J Rhinol. 2006 Nov-Dec;20(6):573-6. doi: 10.2500/ajr.2006.20.2913.
8
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.孟鲁司特可预防阿司匹林诱发哮喘患者的鼻腔赖氨酸-阿司匹林激发试验。
Eur Respir J. 2004 Aug;24(2):226-30. doi: 10.1183/09031936.04.00100303.
9
Aspirin desensitization in patients with AERD.阿司匹林不耐受三联征患者的阿司匹林脱敏治疗
Clin Rev Allergy Immunol. 2003 Apr;24(2):159-68. doi: 10.1385/CRIAI:24:2:159.
10
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.阿司匹林激发的呼吸道疾病哮喘患者的阿司匹林脱敏长期治疗。
J Allergy Clin Immunol. 2003 Jan;111(1):180-6. doi: 10.1067/mai.2003.7.
Zotero 插件